11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid,
4679, KW,
Hydrochloride, Olopatadine,
KW 4679,
KW 4943A,
KW-4679,
KW-4943A,
KW4943A,
olopatadine,
olopatadine hydrochloride,
Patanol,
OLOPATADINE HCl,
OLOPATADINE HYDROCHLORIDE,
140462-76-6,
Pataday,
Allelock,
Patanase,
Opatanol,
ALO4943A,
Olopatadine (hydrochloride),
UNII-2XG66W44KF,
Pazeo,
KW 4679,
2XG66W44KF,
KW-4679,
AL-4943A,
KW4679,
MFCD00875716,
(Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid hydrochloride,
ALO-4943A,
DSSTox_CID_26486,
DSSTox_RID_81657,
DSSTox_GSID_46486,
Olopine,
Patadine,
Olopax,
CHEMBL1719,
11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride,
11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride,
Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-,
Dibenz(b,e)oxepin-2-acetic acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-,
Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-,
CAS-140462-76-6,
Opatanol (TN),
SR-01000763388,
ALO 4943A,
Allelock (TN),
(Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride ;Olopatadine HCL,
Patanol (TN),
DE 114,
Olopatadine hydrochloride [USAN:USP],
Olopatadine Hydrochlorde,
PubChem18816,
O-PPDS,
NCGC00164623-01,
HCl of KW 4679,
AC1NR00D,
SCHEMBL23213,
MLS001401465,
DTXSID0046486,
CHEBI:31933,
HY-B0426A,
HVRLZEKDTUEKQH-NOILCQHBSA-N,
Opatanol;Pataday;Patanase;Allelock,
Olopatadine-hydrochloride(Opatanol),
(11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride,
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride,
EX-A1347,
Olopatadine hydrochloride (Opatanol),
Tox21_112242,
s2494,
AKOS015895232,
AKOS025149118,
Tox21_112242_1,
BCP9001022,
CCG-101141,
CS-2532,
H06O056,
KS-1228,
NC00391,
Olopatadine hydrochloride (JP17/USAN),
NCGC00263532-01,
CPD000469220,
LS-61598,
Olopatadine hydrochloride tablets (JP17),
SAM001246802,
SMR000469220,
Olopatadine hydrochloride, >=98% (HPLC),
AB0107085,
AB2000599,
TL8000904,
O0361,
D01192,
C-21208,
Q-201511,
SR-01000763388-4,
Olopatadine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-acetic acid hydrochloride,
[(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid hydrochloride,
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride,
Patanol,
Olopatadine,
C21H23NO3.HCl,
Olopatadine hydrochloride [USAN],
C21-H23-N-O3.Cl-H,
ACN-040212,
CID5282402,
B1576,
A10671,
113806-05-6,